Evidence suggests that the worldwide prevalence of type 1 diabetes mellitus (T1DM), an autoimmune disease targeting pancreatic beta cells, is following a positive trend. India ranks second for this condition globally, with a prevalence of 818,620 cases. 1 This chronic condition can lead to macrovascular and microvascular complications if left untreated. T1DM autoimmune markers such as GAD, ICA, IA2, ZnT8 2 , and C peptide 3 can detect the disease precisely.
Here is an infographic that briefs about various autoimmune markers in T1DM and the detection using the Metropolis panel. ##References for Introduction:## Gregory GA, Robinson TI, Linklater SE, Wang F, Colagiuri S, de Beaufort C, Donaghue KC, Magliano DJ, Maniam J, Orchard TJ, Rai P. Global incidence, prevalence, and mortality of type 1 diabetes in 2021 with projection to 2040: a modelling study. The lancet Diabetes & endocrinology.…
